−2.05INR
−332.37 MINR
4.58 BINR
16.13 M
About PANACEA BIOTEC LTD.
Sector
Headquarters
New Delhi
Employees (FY)
1.3 K
Website
Founded
1984
ISIN
INE922B01023
FIGI
BBG000DK9Z21
Panacea Biotec Ltd. is a biotechnology company, which engages in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. It operates through the Vaccines and Formulations segments. Its products cover a range of medical areas such as renal disease management, nephrology, oncology, diabetes management, and pediatric vaccines. The company was founded by Soshil Kumar Jain on February 2, 1984 and is headquartered in New Delhi, India.
Trying a new strategy on daily TF .Taking trade on a new TF usually takes trade on weekly and aims for a long trend and about 10% so from now on aiming for daily trade.
#PANACEABIO 165 Buy Recommended- Rachit Sethia PANACEABIO 165
NSE:PANACEABIO
TARGET 225
SL 135
Return 36%
TIME FRAME < 6 Months
RR > 2
Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher Highs & Higher Lows. Broken ab
panacea biotecNew Report on Polio Vaccine Market Evolving Technology and Growth Outlook 2023 to 2031 Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd
Panaceabiotech Short Term BuyIf we look at the chart of panacea biotech it is consolidating since more than 1 month so if breakout happen it will give you easily 20% return because if you see the chart same things are happned may times when it was consolidating and after giving breakout it has given a more than 20% return so i
PANACEA BIOTECH Bearish or Bullish ??1. With sharp fall in the script price , it has well corrected to its low , and is at confluence of Moving averages and ll time Volumteric base at current levels
2. SII has increased stake in Jul 21 , results coming up in Feb , Good stock to keep for 2-3 months target .
3. Effectively using its ca
PANACEABIO LONG INTRADAY 20 APR 2021Dear trader,
If u look at the chart of PANACEABIO (analysis based intraday only) the f PANACEABIO Buy at 270 and
Target at 280.
Best Buy at 268.
Our Best Buy is based on high quality research and when the instrument reaches this level , it’s a jackpot trade.
Best Buy level might be executed or m
Panacea Biotech - Readying for the blast or disappointment againAs you can see Panacea Biotech had wayward price action where stock will make big move with great volumes but disappoint later. Panacea Bio has WHO approved vaccine manufacturing facilities and considering how crunched India is in vaccine availability Panacea is in great spot. This time stock has do
Ride or Die 168 or 259 ?pretty self explanatory waiting to see what happens tomorrow not sure if i load up at 204 since this is a slightly funny stock to trade sort of noticed it moving up when the nifty dips and vice versa
MM also making sure the price keeps getting suppressed with lower highs daily .
210 sort of looks
259 time to FLiP iT ! 287 nextI'd be happy with a 207 entry , recon the dips are for buying on this the last engulfing candle was insane.
Was reading up about the Serum Institute and realised that i can't trade it so looked at what else Adar Poonawalla might do to boost production of the miracle cure ,
One theory is why not
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PANACEABIO is 137.35 INR — it has decreased by 1.36% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange PANACEA BIOTEC LTD. stocks are traded under the ticker PANACEABIO.
PANACEA BIOTEC LTD. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
PANACEABIO stock is 3.59% volatile and has beta coefficient of 0.89. Check out the list of the most volatile stocks — is PANACEA BIOTEC LTD. there?
Yes, you can track PANACEA BIOTEC LTD. financials in yearly and quarterly reports right on TradingView.
PANACEABIO stock has fallen by 6.82% compared to the previous week, the month change is a 0.51% fall, over the last year PANACEA BIOTEC LTD. has showed a 13.84% increase.
PANACEABIO net income for the last quarter is −22.80 M INR, while the quarter before that showed −83.70 M INR of net income which accounts for 72.76% change. Track more PANACEA BIOTEC LTD. financial stats to get the full picture.
Today PANACEA BIOTEC LTD. has the market capitalization of 8.53 B, it has increased by 6.00% over the last week.
No, PANACEABIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PANACEABIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PANACEA BIOTEC LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 1.30 K employees. See our rating of the largest employees — is PANACEA BIOTEC LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PANACEA BIOTEC LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PANACEA BIOTEC LTD. stock shows the sell signal. See more of PANACEA BIOTEC LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PANACEA BIOTEC LTD. EBITDA is −196.90 M INR, and current EBITDA margin is −14.59%. See more stats in PANACEA BIOTEC LTD. financial statements.